News Releases

Mayo Clinic Develops First-in-U.S. Neurology Test to Distinguish Spectrum of Autoimmune Demyelinating Diseases from Multiple Sclerosis featured image
Mayo Clinic Develops First-in-U.S. Neurology Test to Distinguish Spectrum of Autoimmune Demyelinating Diseases from Multiple Sclerosis

Mayo Clinic has launched a first-in-the-U.S. clinical test that will help patients who recently have been diagnosed with an inflammatory demyelinating disease but may be unsure of the exact disorder.

By Gina Chiri-Osmond • November 28, 2017